Pierre P Massion

12PUBLICATIONS
34CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Disease surveillancePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 19, 2022
Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination.

Amanda K Kussrow, Michael N Kammer, Pierre P Massion

|Jan 25, 2021
National Lung Cancer Screening Utilization Trends in the Veterans Health Administration.

Jennifer A Lewis, Lauren R Samuels, Jason Denton

|Jan 05, 2021
Establishing a Cohort and a Biorepository to Identify Biomarkers for Early Detection of Lung Cancer: The Nashville Lung Cancer Screening Trial Cohort.

Dhairya A Lakhani, Sheau-Chiann Chen, Sanja Antic

|Nov 20, 2020
Mortality for Robotic- vs Video-Assisted Lobectomy-Treated Stage I Non-Small Cell Lung Cancer Patients.

Yong Cui, Eric L Grogan, Stephen A Deppen

|Nov 03, 2020
Reply to Wilson: Risk-Stratifying Pulmonary Nodules.

Pierre P Massion

|Sep 26, 2020
A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking.

Emily B Harrison, Alessandro Porrello, Brittany M Bowman

Pageof 2

Frequent Collaborators

3 joint publications

Xiao-Ou Shu

2 joint publications

Michael N Kammer

2 joint publications

Stephanie M Cohen

2 joint publications

Eric L Grogan